More than 3 in 4 injection users would consider switching 76.76% of current and previous GLP-1 injection users said they would likely switch to a tablet version if it offered similar effectiveness and cost
Collectively, these observations support the view that inter-individual variability in GLP-1 RA efficacy may, at least in part, reflect differences in baseline gut barrier integrity and microbiome functional capacity, which may distinguish responders from non-responders
1 This approach is designed to be sustainable after medication stops, because it doesnt rely on a tracking system you might abandon
This is especially dangerous if you have diabetes or are taking other medications that can lower your blood sugar
Avoid carbonated drinks and limit artificial sweeteners
The next two years will be very critical for long-term winners in this space as global and domestic pharmaceutical companies accelerate commercial preparations